Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
El-Tanani et al., Pharmaceuticals, doi:10.3390/ph16060799
https://c19early.org/eltananimb.html